A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...

Oprah Winfrey is sharing new details on her weight loss in recent years, including the kind of weight loss drug she took. In a recent episode of "The Oprah Podcast", she said that she took a GLP-1 ...

She showed off her new look and shocked fans Throughout her health journey, her fans seemed to notice her weight loss more than she did. “I don’t really see it because if anyone who’s on a ...